Reproductive Rights and the State: Getting the Birth Control, RU-486, Morning-after Pills and the Gardasil Vaccine to the U.S. Market
ABC-CLIO, 2013 - 184 páginas
Simultaneously examining four significant, never-before-combined case studies, this unique feminist analysis offers troubling revelations about the private-public interaction in U.S. policy affecting birth control drugs.
To make her case, Melissa Haussman scrutinizes the history of the FDA and the statutes that have governed it, as well as interactions between the U.S. government, American pharmaceutical companies, and the medical community. The analysis centers on explaining how three reproductive drugs were kept off the U.S. market well after their efficacy had been proven, while the availability of the fourth, Gardasil, has less to do with helping girls than with preserving the financial wellbeing of Merck. Readers will come away understanding how, when it comes to reproductive drugs, women's health concerns have consistently taken a backseat to political agendas and corporate profits.
Comentarios de la gente - Escribir un comentario
2 History of the FDA and Drug Regulation in the United States
3 The Development of the Pill
4 US ProChoice and ProLife Groups Strategies since 1960
5 Problems with Mifepristone RU486 and Misoprostol Cytotec 19882000
6 The MorningAfter Pill Plan B Levonorgestrel Formulation